The estimated Net Worth of Aleksandra Krusko is at least $2.3 Миллион dollars as of 13 September 2021. Aleksandra Krusko owns over 27 units of Cencora stock worth over $2,252,594 and over the last 4 years Aleksandra sold COR stock worth over $42,517.
Aleksandra has made over 3 trades of the Cencora stock since 2021, according to the Form 4 filled with the SEC. Most recently Aleksandra sold 27 units of COR stock worth $3,985 on 13 September 2021.
The largest trade Aleksandra's ever made was selling 301 units of Cencora stock on 15 March 2021 worth over $34,883. On average, Aleksandra trades about 90 units every 47 days since 2021. As of 13 September 2021 Aleksandra still owns at least 9,536 units of Cencora stock.
You can see the complete history of Aleksandra Krusko stock trades at the bottom of the page.
Aleksandra's mailing address filed with the SEC is C/O CORESITE REALTY CORPORATION, 1001 17TH STREET, SUITE 500, DENVER, CO, 80202.
Over the last 14 years, insiders at Cencora have traded over $67,682,023 worth of Cencora stock and bought 34,206 units worth $1,080,918 . The most active insiders traders include Realty Iii, Gp, L.L.C.Carly..., Iv Aiv Gp, L.L.C.Crp Iv Aiv... и Group Management L.L.C.Carl.... On average, Cencora executives and independent directors trade stock every 13 days with the average trade being worth of $18,365,869. The most recent stock trade was executed by Brian Warren on 5 November 2021, trading 850 units of COR stock currently worth $130,577.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Cencora executives and other stock owners filed with the SEC include: